Subsidy Tracker

Basic Search | Geographic Searches | Advanced Search | Megadeals

Subsidy Tracker Parent Company Summary

Parent Company Name: GlaxoSmithKline
Ownership Structure: publicly traded (ticker symbol LSE: GSK)
Headquartered in: United Kingdom
Major Industry: pharmaceuticals
Specific Industry: pharmaceuticals

Subsidy Summary	Subsidy Value	Number of Awards
State/Local	$58,753,398	44
Federal (grants and allocated tax credits)	$4,741,401	2
TOTAL	$63,494,799	46
Loan / Bailout Summary	Total Face Value	Number of Awards
State/Local loans, bond financing and venture capital	$0	0
Federal loans, loan guarantees and bailout assistance (not including repayments)	$0	0
TOTAL	$0	0

Time Period for Federal Awards: FY2000 to the present
Notes: Dollar totals do not include awards for which no subsidy value is disclosed.
Links: For a summary of this company's regulatory violations see its Violation Tracker summary page here.

For an overview of this company's accountability track record, read its Corporate Rap Sheet here.

Top 5 States for state/local awards	Total Subsidy $	Number of Awards
North Carolina	$27,741,773	13
Pennsylvania	$24,726,591	15
New York	$5,103,881	10
Washington	$935,632	4
Montana	$240,000	1
All other	$5,521	1

Individual Subsidy Records:

Click on the company name for more information on each subsidy award.

Download results as CSV or XML or Save your search (Click here for information on download subscriptions)

Company	Location	Subsidy Source	Year	Subsidy Value	Type of Subsidy
GlaxoSmithkline Holdings Americas , Inc.	North Carolina	state	2015	$8,524,608	tax credit/rebate
GlaxoSmithkline Holdings Americas , Inc.	North Carolina	state	2013	$4,414,142	tax credit/rebate
GlaxoSmithKline, LLC ( f/k/a SmithKline Beecham Corporation)	Pennsylvania	state	2012	$4,247,696	tax credit/rebate
GlaxoSmithkline Holdings Americas , Inc.	North Carolina	state	2016	$4,121,650	tax credit/rebate
GlaxoSmithkline Holdings Americas , Inc.	North Carolina	state	2011	$4,039,279	tax credit/rebate
GlaxoSmithKline Holdings Americas , Inc.	North Carolina	state	2012	$4,025,543	tax credit/rebate
GlaxoSmithKline	United States	federal	2012	$4,011,709	federal grant
GLAXOSMITHKLINE LLC	Pennsylvania	state	2020	$3,388,900	tax credit/rebate
GlaxoSmithKline, LLC (f/k/a SmithKline Beecham Corporation)	Pennsylvania	state	2014	$3,353,317	tax credit/rebate
SmithKline Beecham Corporation DBA GlaxoSmithKline	Pennsylvania	state	2008	$2,990,917	tax credit/rebate
GlaxoSmithKline, LLC ( f/k/a SmithKline Beecham Corporation)	Pennsylvania	state	2013	$2,357,066	tax credit/rebate
GlaxoSmithKline, LLC (f/k/a SmithKline Beecham Corporation)	Pennsylvania	state	2015	$2,269,398	tax credit/rebate
GlaxoSmithKline Beecham Corp	North Carolina	state	2005	$1,859,000	grant
GlaxoSmithKline Biologicals North America dba Corixa	Pennsylvania	state		$1,350,000	tax credit/rebate
GlaxoSmithKline Biologicals North America dba Corixa	Pennsylvania	state		$1,350,000	grant
GlaxoSmithKline	Pennsylvania	state	2010	$1,000,000	grant
SmithKline Beecham Corporation DBA GlaxoSmithKline	Pennsylvania	state	2011	$951,581	tax credit/rebate
GlaxoSmithKline	United States	federal	2012	$729,692	federal grant
GLAXOSMITHKLINE & Stiefel Laboratories Inc.	New York	local	2020	$588,821	tax credit/rebate
GLAXOSMITHKLINE & Stiefel Laboratories Inc.	New York	local	2019	$556,419	tax credit/rebate
GLAXOSMITHKLINE & Stiefel Laboratories Inc.	New York	local	2017	$540,625	tax credit/rebate
GLAXOSMITHKLINE & Stiefel Laboratories Inc.	New York	local	2015	$534,097	tax credit/rebate
GLAXOSMITHKLINE & Stiefel Laboratories Inc.	New York	local	2016	$534,097	tax credit/rebate
GlaxoSmithKline LLC	Pennsylvania	state	2010	$500,000	grant
GLAXOSMITHKLINE & Stiefel Laboratories Inc.	New York	Local	2018	$494,593	tax credit/rebate
GLAXOSMITHKLINE & Stiefel Laboratories Inc.	New York	local	2011	$488,081	tax credit/rebate; property tax abatement
GLAXOSMITHKLINE & Stiefel Laboratories Inc.	New York	local	2013	$470,487	tax credit/rebate; property tax abatement
GLAXOSMITHKLINE & Stiefel Laboratories Inc.	New York	local	2012	$464,160	tax credit/rebate; property tax abatement
SmithKline Beecham Corporation DBA GlaxoSmithKline	Pennsylvania	state	2010	$435,635	tax credit/rebate
GLAXOSMITHKLINE & Stiefel Laboratories Inc.	New York	local	2014	$432,501	tax credit/rebate
GLAXOSMITHKLINE BIOLOGICALS NORTH AMERICA	Washington	state	2006	$397,686	tax credit/rebate
GlaxoSmithKline Biologicals North America	Pennsylvania	state		$316,181	training reimbursement
GLAXOSMITHKLINE BIOLOGICALS NORTH AMERICA	Washington	state	2004	$253,000	tax credit/rebate
GlaxoSmithKline Biologicals	Montana	state	2011	$240,000	grant/loan hybrid program
GlaxoSmithKline	Pennsylvania	state		$200,000	training reimbursement
GlaxoSmithkline Holdings Americas, Inc.	North Carolina	state	2015	$171,518	tax credit/rebate
GLAXOSMITHKLINE BIOLOGICALS NORTH AMERICA	Washington	state	2004	$168,442	tax credit/rebate
GlaxoSmithkline Holdings Americas , Inc.	North Carolina	state	2013	$167,753	tax credit/rebate
GLAXOSMITHKLINE BIOLOGICALS NORTH AMERICA	Washington	state	2007	$116,504	tax credit/rebate
GlaxoSmithkline Holdings Americas	North Carolina	state	2011	$83,656	tax credit/rebate
GlaxoSmithkline Holdings Americas , Inc.	North Carolina	state	2010	$83,656	tax credit/rebate
GlaxoSmithkline Holdings Americas , Inc.	North Carolina	state	2012	$83,656	tax credit/rebate
GlaxoSmithkline Holdings Americas , Inc.	North Carolina	state	2013	$83,656	tax credit/rebate
GlaxoSmithkline Holdings Americas , Inc.	North Carolina	state	2015	$83,656	tax credit/rebate
Glaxosmithkline Consumer Healthcare Hold	Pennsylvania	state	2021	$15,900	tax credit/rebate
GLAXOWELLCOME INC	Tennessee	local	2008	$5,521	property tax abatement